Therapeutic formulation for administering tolterodine with controlled release
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 3, 2004
Grant Date -
N/A
app pub date -
Aug 9, 2000
filing date -
Aug 27, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is drawn to a method of treating an unstable or overactive urinary bladder by treating the patient with tolterodine or a tolterodine-related compound, or pharmaceutically acceptable salt thereof, with a controlled release formulation that maintains a substantially constant serum level of the active moiety or moieties for at least 24 hours. The present invention is further drawn to a formulation for the method.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully